30 related articles for article (PubMed ID: 11469928)
1. Variations in Persistent Use of Low-Value Breast Cancer Surgery.
Wang T; Bredbeck BC; Sinco B; Shubeck S; Baskin AS; Skolarus T; Dossett LA
JAMA Surg; 2021 Apr; 156(4):353-362. PubMed ID: 33533894
[TBL] [Abstract][Full Text] [Related]
2. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.
Simunovic M; Thériault ME; Paszat L; Coates A; Whelan T; Holowaty E; Levine M
Can J Surg; 2005 Apr; 48(2):137-42. PubMed ID: 15887794
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in the use of surgery in Ontario.
Feinberg AE; Porter J; Saskin R; Rangrej J; Urbach DR
CMAJ Open; 2015; 3(3):E310-6. PubMed ID: 26442230
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
[No Abstract] [Full Text] [Related]
8. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
9. The rate of breast-conserving surgery for early breast cancer is not influenced by the surgical strategy of excisional biopsy followed by the definitive procedure.
Petrik DW; McCready DR; Goel V; Pinfold SP; Sawka CA
Breast J; 2001; 7(3):158-65. PubMed ID: 11469928
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
12. De-escalating and escalating surgery in the management of early breast cancer.
Morrow M
Breast; 2017 Aug; 34 Suppl 1():S1-S4. PubMed ID: 28673537
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
